Advertisement
Original report| Volume 3, ISSUE 2, P82-87, 1999

Molecular fingerprinting of mupirocin-resistant methicillin-resistant Staphylococcus aureus from a burn unit

Open ArchiveDOI:https://doi.org/10.1016/S1201-9712(99)90014-0
Molecular fingerprinting of mupirocin-resistant methicillin-resistant Staphylococcus aureus from a burn unit
Previous ArticleBiomolecular techniques to detect Pneumocystis carinii f. sp. hominis pneumonia in patients with acquired immunodeficiency syndrome
Next ArticleEtiology of central nervous system infections in the Philippines and the role of serum C-reactive protein in excluding acute bacterial meningitis
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Objectives: To characterize mupirocin-resistant methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients in a burn unit by pulsed-field gel electrophoresis and plasmid contents.
      Methods: A total of 53 methicillin-resistant S. aureus, consisting of 48 mupirocin-resistant and 5 mupirocin-susceptible MRSA were compared by plasmid content and pulsed-field gel electrophoresis of Sma I digested genomic DNA.
      Results: Of the 48 mupirocin-resistant isolates, 39 expressed high-level, and 9 expressed low-level mupirocin resistance. Plasmids were detected in all of the 53 isolates; however, only the high-level mupirocin-resistant isolates contained a 38 kb-conjugative plasmid that encoded high-level mupirocin resistance. Pulsed-field gel electrophoresis divided the isolates into four patterns designated types I to IV Forty-three isolates consisting of 34 high-level, 5 low-level mupirocin-resistant and 4 mupirocin-susceptible isolates defined the type-I pattern. Eight isolates, five high-level and three low-level mupirocin-resistant isolates had the type-II pulsed-field pattern. The type-III and type-IV pulsed-field patterns consisted of a single isolate each. The typed and type-II pulsed-field patterns were related and only differed by four Sma I bands.
      Conclusions: Results of typing the mupirocin-resistant MRSA that closely related MRSA clones previously circulating in the unit had acquired a high-level mupirocin-resistant plasmid, and spread aided by mupirocin use.

      Keywords

      References

        • Cookson B.D.
        The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice.
        J Antimicrob Chemother. 1998; 41: 11-18
        • Breneman D.L.
        Use of mupirocin ointment in the treatment of secondary infected dermatoses.
        J Am Acad Dermatol. 1990; 22: 886-892
        • Rode H.
        • Hanslo D.
        • deWet P.M.
        • Millar J.W.
        • Cywes S.
        Efficacy of mupirocin in methicillin-resistant burn wound infections.
        Antimicrob Agents Chemother. 1989; 33: 1358-1361
        • Denning D.W.
        • Haiduven-Griffiths D.
        Eradication of low-level methicillin-resistant Staphylococcus aureus skin colonization with topical mupirocin.
        Infect Control Hosp Epidemiol. 1988; 9: 261-263
        • Welsh O.
        • Saenz C.
        Topical mupirocin compared with oral ampicillin in the treatment of primary and secondary skin infections.
        Curr Ther Res. 1987; 42: 114-120
        • Lever R.
        • Hadley K.
        • Downey D.
        • Mackie R.
        Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy.
        Br J Dermatol. 1988; 119: 189-198
        • Luber H.
        • Amornsisripanitich S.
        • Lucky A.W.
        Mupirocin and eradication of Staphylococcus aureus in atopic dermatitis.
        Arch Dermatol. 1988; 124: 853-854
        • Strock L.L.
        • Lee M.M.
        • Rutan R.L.
        • et al.
        Topical Bactroban (mupirocin) in treating burn wounds infected with methicillin-resistant staphylococci.
        J Burn Care Rehabil. 1990; 11: 454-459
        • Czarnecki D.B.
        • Nash C.G.
        • Bohl T.G.
        The use of mupirocin before skin surgery.
        Int J Dermatol. 1991; 30: 218-219
        • Casewell M.W.
        • Hill R.L.R.
        Elimination of nasal carriage of Staphylococcus aureus with mupirocin (pseudomonic acid): a controlled trial.
        J Antimicrob Chemother. 1986; 17: 365-372
        • Hill R.L.
        • Duckworth G.L.
        • Casewell M.W.
        Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.
        J Antimicrob Chemother. 1988; 22: 377-384
        • Barret S.P.
        The value of nasal mupirocin in containing an outbreak of methicillin-resistant Staphylococcus aureus in an orthopedic unit.
        J Hosp Infect. 1990; 15: 137-142
        • Gaspar M.C.
        • Sanchez P.
        • Uribe P.
        • Coello R.
        • Arroyo P.
        • Cruzet E.
        Mupirocin susceptibility in vitro and nasal eradication of epidemic methicillin-resistant Staphylococcus aureus.
        J Hosp Infect. 1993; 24: 237-238
        • Rahman M.
        • Noble W.C.
        • Cookson B.D.
        Transmissible mupirocin resistance in Staphylococcus aureus.
        Epidemiol Infect. 1989; 102: 261-270
        • Smith G.E.
        • Kennedy C.T.C.
        Staphylococcus aureus resistant to mupirocin.
        J Antimicrob Agents Chemother. 1988; 21: 141-142
        • Moy J.A.
        • Caldwell-Brown D.
        • Lin A.N.
        • Pappa K.A.
        • Carter D.M.
        Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa.
        J Am Acad Dermatol. 1990; 22: 893-895
        • Udo E.E.
        • Pearman J.W.
        • Grubb W.B.
        Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus in western Australia.
        J Hosp Infect. 1994; 26: 157-165
        • Netto dos Santos K.R.
        • de Souza Fonseca L.
        • Filho P.P.G.
        Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian hospitals.
        Infect Control Hosp Epidemiol. 1996; 17: 813-815
        • Layton M.C.
        • Patterson J.E.
        Mupirocin resistance among consecutive isolates of oxacillin-resistant and borderline oxacillin-resistant Staphylococcus aureus at a university hospital.
        Antimicrob Agents Chemother. 1994; 38: 1664-1667
        • Cookson B.D.
        • Lacey R.W.
        • Noble W.C.
        • Reeves D.S.
        • Wise R.
        • Redhead R.J.
        Mupirocin-resistant Staphylococcus aureus.
        Lancet. 1990; 335: 1095-1096
        • Lang S.
        • Raymond N.
        • Brett M.
        Mupirocin-resistant Staphylococcus aureus in Auckland.
        N Z Med J. 1992; 105: 438
        • Kauffman C.A.
        • Terpenning M.S.
        • He X.
        • et al.
        Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term care facility with the use of mupirocin.
        Am J Med. 1993; 94: 371-378
        • Connolly S.
        • Noble W.C.
        • Phillips I.
        Mupirocin resistance in coagulase-negative staphylococci.
        J Med Microbiol. 1993; 39: 450-453
        • Gilbart J.
        • Perry C.R.
        • Slocombe B.
        High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl tRNA synthetase.
        Antimicrob Agents Chemother. 1993; 37: 32-38
      25. Bactroban ointment. Product Profile. SmithKline Beecham, 1992
        • Udo E.E.
        • Jacob L.E.
        • Mokadas E.M.
        Conjugative transfer of highlevel mupirocin resistance from Staphylococcus haemolyticus to other staphylococci.
        Antimicrob Agents Chemother. 1997; 41: 693-695
        • National Committee for Clinical Laboratory Standards
        Performance standards for antimicrobial disk susceptibility tests.
        National Committee for Clinical Laboratory Standards, Villanova, Pennsylvania1993
        • Townsend D.E.
        • Ashdown N.
        • Bolton S.
        • Grubb W.B.
        The use of cetyltrimethylammonium bromide for the rapid isolation from Staphylococcus aureus of relaxable plasmid DNA for in vitro manipulation.
        Letts Appl Microbiol. 1985; 1: 87-94
        • Udo E.E.
        • Grubb W.B.
        Genetic analysis of methicillin-resistant Staphylococcus aureus from a Nigerian hospital.
        J Med Microbiol. 1993; 38: 203-208
        • Tenover F.C.
        • Arbeit R.D.
        • Goering R.V.
        • et al.
        Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.
        J Clin Microbiol. 1995; 33: 2233-2239

      Article info

      Publication history

      Accepted: January 16, 1999
      Received: July 22, 1998

      Footnotes

      ☆Presented in part at the 8th International Congress on infectious Diseases, Boston, Massachusetts, May 15–18, 1998.

      Identification

      DOI: https://doi.org/10.1016/S1201-9712(99)90014-0

      Copyright

      © 1999 Published by Elsevier Inc.

      User license

      Elsevier user license |
      How you can reuse Information Icon
      Elsevier user license

      Permitted

      For non-commercial purposes:

      • Read, print & download
      • Text & data mine
      • Translate the article

      Not Permitted

      • Reuse portions or extracts from the article in other works
      • Redistribute or republish the final article
      • Sell or re-use for commercial purposes

      Elsevier's open access license policy

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX